The implantable neurostimulator electrode market is projected to grow from USD 1.3 billion in 2026 to USD 2.6 billion by 2036, at a CAGR of 7.0%. Directional Leads will dominate with a 40.0% market share, while DBS will lead the application segment with a 40.0% share.